Fourier transform infrared imaging analysis in discrimination studies of bladder cancer

Literature Information

Publication Date 2013-07-04
DOI 10.1039/C3AN01101A
Impact Factor 4.616
Authors

C. Pezzei, A. Brunner, G. K. Bonn, C. W. Huck



Abstract

Bladder carcinoma represents more than 4% of all cancer diseases in Austria. The histomorphological evaluation is invasive and remains a subjective and time consuming technique. On account of this it is necessary to find novel non-invasive approaches which support the pathologists for histological recognition to identify malignancy at an early stage. In the present study, Fourier transform infrared (FTIR) microscopic imaging was combined with univariate and multivariate data analysis methods to study bladder carcinoma tissue sections in detail. The possibility to collect IR spectra of bladder carcinoma tissue sections employing an optimized analytical protocol is demonstrated. The correlation between FTIR microscopic imaging and the morphological tissue features obtained by histological staining of the sections demonstrated that many histomorphological tissue patterns can be visualized in the colour images. The routine generation of high quality imaging data is enabled because of the combination of FTIR technology and optimized sample preparation techniques. This opens a new quality of spectroscopic analyses of cancerous tissue, allowing exploration of molecular changes associated with the histopathological morphology.

Source Journal

Analyst

Analyst
CiteScore: 7.8
Self-citation Rate: 5.6%
Articles per Year: 653

Analyst publishes analytical and bioanalytical research that reports premier fundamental discoveries and inventions, and the applications of those discoveries, unconfined by traditional discipline barriers.

Recommended Suppliers

SwitzerlandChemgo Organica Ag
ChinaJinan Ruduo Chemical Co., Ltd.
ChinaAdvan pharmachem co., ltd
ChinaGansu Screw Compressor Parts Co., Ltd
GermanyICS GmbH
GermanyELEKTRO-WÄRME-AACHEN Adam Gruszka
GermanyLaser Zentrum Hannover e.V. (LZH)
ChinaAnhui Yilin Pharmaceutical Co., Ltd.
GermanyCNGR Advanced Materials Co.
ChinaShenzhen Excellent Technology Co., Ltd.
Disclaimer
This page provides academic journal information for reference and research purposes only. We are not affiliated with any journal publishers and do not handle publication submissions. For publication-related inquiries, please contact the respective journal publishers directly.
If you notice any inaccuracies in the information displayed, please contact us at [email protected]. We will promptly review and address your concerns.